-transparent.png){kind=logo}
In a single dose clinical investigation two buffered acetylsalicylic acid formulations (Ascriptin and Ascriptin A/D) were shown to be significantly less irritating to the human gastric mucosa than acetylsalicylic acid, and no more irritating than a pharmacologically inert placebo. The measurements were taken using a minimally invasive method for recording transmural gastric potential difference changes versus time.
Related Publications
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
May 1992,
Arzneimittel-Forschung,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
January 1985,
Gastroenterologie clinique et biologique,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
July 1987,
Methods and findings in experimental and clinical pharmacology,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
April 1975,
Lakartidningen,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
February 2004,
Alimentary pharmacology & therapeutics,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
February 1970,
The American journal of digestive diseases,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
April 1976,
Lakartidningen,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
February 1977,
International journal of clinical pharmacology and biopharmacy,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
January 1981,
Archivio per le scienze mediche,
R Bruhn, and
D P Ganote, and
P W Lücker, and
J Vance, and
R L Procaccini
January 1992,
International journal of clinical pharmacology research,
